147 related articles for article (PubMed ID: 177250)
1. Increased serum calcitonin levels in bronchogenic cancer.
Silva OL; Becker KL; Primack A; Doppman JL; Snider RH
Chest; 1976 Apr; 69(4):495-9. PubMed ID: 177250
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcitonemia in bronchogenic cancer. Evidence for thyroid origin of the hormone.
Silva OL; Becker KL; Primack A; Doppman JL; Snider RH
JAMA; 1975 Oct; 234(2):183-5. PubMed ID: 1242155
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin as a marker for bronchogenic cancer: a prospective study.
Silva OL; Broder LE; Doppman JL; Snider RH; Moore CF; Cohen MH; Becker KL
Cancer; 1979 Aug; 44(2):680-4. PubMed ID: 476577
[TBL] [Abstract][Full Text] [Related]
4. Ectopic production of calcitonin.
Silva OL; Becker KL; Primack A; Doppman J; Snider RH
Lancet; 1973 Aug; 2(7824):317. PubMed ID: 4124787
[No Abstract] [Full Text] [Related]
5. Serum calcitonin after pentagastrin stimulation in patients with bronchogenic and breast cancer compared to that in patients with medullary thyroid carcinoma.
Samaan NA; Castillo S; Schultz PN; Khalil KG; Johnston DA
J Clin Endocrinol Metab; 1980 Aug; 51(2):237-41. PubMed ID: 6249833
[TBL] [Abstract][Full Text] [Related]
6. Ectopic hormones in lung cancer patients at diagnosis and during therapy.
Gropp C; Havemann K; Scheuer A
Cancer; 1980 Jul; 46(2):347-54. PubMed ID: 6248192
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.
Winkelmann W; Deuss U; Allolio B; Hummerich W; Kaulen D; Brosch H; Guyot A; Arnold C
Klin Wochenschr; 1984 Nov; 62(21):1018-24. PubMed ID: 6096627
[TBL] [Abstract][Full Text] [Related]
9. Urine calcitonin levels in patients with bronchogenic carcinoma.
Becker KL; Nash DR; Silva OL; Snider RH; Moore CF
JAMA; 1980 Feb; 243(7):670-2. PubMed ID: 6243372
[TBL] [Abstract][Full Text] [Related]
10. Ectopic secretion of calcitonin by oat-cell carcinoma.
Silva OL; Becker KL; Primack A; Doppman J; Snider RH
N Engl J Med; 1974 May; 290(20):1122-4. PubMed ID: 4362473
[No Abstract] [Full Text] [Related]
11. Clinical utility of hyaluronic acid values in serum and bronchoalveolar lavage fluid as tumor marker for bronchogenic carcinoma.
Hernández Hernández JR; García García JM; Martínez Muñíz MA; Allende Monclus MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):149-55. PubMed ID: 8551057
[TBL] [Abstract][Full Text] [Related]
12. Elevated prolactin levels in bronchogenic carcinoma.
Davis S; Proper S; May PB; Ertel NH
Cancer; 1979 Aug; 44(2):676-9. PubMed ID: 225000
[TBL] [Abstract][Full Text] [Related]
13. Tissue polypeptide antigen in bronchogenic carcinoma.
Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis in human bronchogenic carcinoma.
Peterson HI; Larsson S; Zettergren L
Bibl Anat; 1975; 13():315-6. PubMed ID: 182114
[No Abstract] [Full Text] [Related]
15. Circulating blood RNA in lung cancer.
Behera D; Mallik SK; Dani HM; Gumbhir K
J Assoc Physicians India; 1986 Aug; 34(8):579-80. PubMed ID: 2432053
[No Abstract] [Full Text] [Related]
16. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Bitran JD; Desser RK; DeMeester TR; Colman M; Evans R; Billings A; Griem M; Rubenstein L; Shapiro C; Golomb HM
Cancer Treat Rep; 1976 Sep; 60(9):1225-30. PubMed ID: 189920
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoreactive calcitonin in lung cancer.
Conte N; Cecchettin M; Manente P; Monco MA; Salandin F; Volpato E; Roiter I; Carniato A
Tumori; 1984 Apr; 70(2):137-40. PubMed ID: 6328714
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
19. Circulating hormones in lung cancer.
Behera D; Malik SK; Sharma BR; Dash RJ
Indian J Med Res; 1984 May; 79():636-40. PubMed ID: 6096269
[No Abstract] [Full Text] [Related]
20. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
Davis S; May PB
Am J Med Sci; 1982; 283(1):2-7. PubMed ID: 6275702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
